Novel factor Xa inhibitors based on a benzoic acid scaffold and incorporating a neutral P1 ligand

A series of novel, highly potent, achiral factor Xa inhibitors based on a benzoic acid scaffold and containing a chlorophenethyl moiety directed towards the protease S1 pocket is described. The compound shown was found to be the most active in a number of antithrombotic assays. A series of novel, hi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry letters 2004-06, Vol.14 (11), p.2801-2805
Hauptverfasser: Nazaré, Marc, Matter, Hans, Klingler, Otmar, Al-Obeidi, Fahad, Schreuder, Herman, Zoller, Gerhard, Czech, Jörg, Lorenz, Martin, Dudda, Angela, Peyman, Anusch, Nestler, Hans Peter, Urmann, Matthias, Bauer, Armin, Laux, Volker, Wehner, Volkmar, Will, David W.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:A series of novel, highly potent, achiral factor Xa inhibitors based on a benzoic acid scaffold and containing a chlorophenethyl moiety directed towards the protease S1 pocket is described. The compound shown was found to be the most active in a number of antithrombotic assays. A series of novel, highly potent, achiral factor Xa inhibitors based on a benzoic acid scaffold and containing a chlorophenethyl moiety directed towards the protease S1 pocket is described. A number of structural features, such as the requirements of the P1, P4 and ester-binding pocket ligands were explored with respect to inhibition of factor Xa. Compound 46 was found to be the most potent compound in a series of antithrombotic secondary assays.
ISSN:0960-894X
1464-3405
DOI:10.1016/j.bmcl.2004.03.059